🇺🇸

Broad Market

· daily

Global High-Priority Regulatory Events — June 10, 2026

This digest covers 50 filings from June 10, 2026, revealing a market bifurcated between high-stakes corporate events (insolvencies, M&A, and capital raises) and routine regulatory compliance. A significant cluster of insolvency filings (Kallam Textiles, Parsvnath Developers, Evoq Remedies) signals distress in the Indian corporate sector, while major M&A transactions (Corebridge/Equitable, Einride/Legato, Mkango/Crown PropTech) indicate active consolidation. Period-over-period comparisons show a stark contrast: Toyota's 2.5% sales growth masks a ¥1 trillion operating income decline, while Chewy's 51.9% net income surge highlights consumer resilience. Insider activity is limited but notable, with Gandhar Oil's promoter increasing his stake by 0.05% and multiple pledge adjustments at Anand Rathi Wealth and Responsive Industries. Forward-looking data points to significant catalysts, including the Corebridge merger closing by year-end 2026 and Teamshares' aggressive EBITDA growth forecast from $19M to $100M by 2027. Capital allocation trends are mixed, with Core & Main prioritizing share buybacks ($88M) over growth, while Hut 8 commits $4.25B to data center development. The overall theme is one of strategic realignment, with companies either pursuing transformative M&A or facing existential threats from insolvency.

50 high priority 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — June 10, 2026

Overnight filings reveal a market bifurcated between aggressive capital deployment and acute financial distress. A dominant theme is the massive scale of debt financing for infrastructure buildouts, with Hut 8's $4.25B data center notes and Rocket Companies' $1.5B refinancing highlighting a 'bigger is better' strategy in high-growth sectors. Conversely, a cluster of micro-cap companies (Vanguard Green, RemSleep, Silver Bull) are reporting zero revenue, widening losses, and cash burn rates that threaten their viability. The SPAC market is active with two significant de-SPACs (Einride, Mkango) and one major merger update (Paramount Skydance), signaling a potential thaw in the blank-check space. Insider activity is sparse, but capital allocation is a key differentiator: Chewy and Core & Main are aggressively buying back shares, while News Corp authorized a $1B repurchase program. Period-over-period comparisons show a clear divergence, with consumer-facing names like J.Jill (-6% sales) struggling, while Chewy (+7.7% sales) and Toyota (+2.5% unit sales) demonstrate resilience. The most critical development is the Paramount Skydance/WBD merger receiving key regulatory approvals, removing a major overhang, while the most acute risk is the existential cash crisis at Vanguard Green Investment, which has only $55 in cash.

24 high priority 26 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — June 09, 2026

This digest analyzes 50 SEC filings from June 9, 2026, revealing a market dominated by transformative M&A, significant financial distress, and strategic realignments. A major theme is large-scale consolidation in the specialty ingredients and biotech sectors, with Ingredion's ~$5.0B acquisition of Tate & Lyle and GSK's $10.6B acquisition of Nuvalent signaling high premiums and expectations of future synergies. Alongside these bullish moves, there is a stark contrast of corporate distress, with Getaround entering a final dissolution phase and Aditxt resorting to heavily discounted debt financing, creating pronounced risk flags. A second key theme is the aggressive use of capital markets, with multiple companies (Arch Capital, Cheniere Energy) issuing large blocks of debt, while Novanta uses a $300M equity raise to partly fund a high-multiple acquisition. Insider activity and executive changes were widespread, from routine CFO transitions at Wendy's and Grocery Outlet to the sudden exit of two senior executives at comScore, hinting at organizational stress. Forward-looking data builds a clear catalyst calendar, with major milestones including the Nuvalent/GSK deal close in Q3 2026, FDA review decisions for Nuvalent's drugs in September and November 2026, and the Ingredion/Tate & Lyle deal closing in H2 2027. The overall market sentiment is bifurcated: confident long-term bets from well-capitalized players vs. distress financing and operational failures in weaker companies.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — June 09, 2026

Today's filings reveal a market bifurcated between aggressive capital deployment and underlying operational fragility. The most dominant theme is a wave of high-value M&A, led by GSK's $10.6 billion acquisition of Nuvalent and Novanta's $1.2 billion purchase of Riverpoint Medical, signaling strong corporate confidence in targeted therapeutic and med-tech spaces. However, this is contrasted by a cluster of micro-cap companies (AITX, AIBOTICS, Onconetix) showing severe financial distress, with going concern warnings and cash balances under $4 million. The SPAC market is active, with three new business combination filings (Inflection Point/Quantum Space, IQM/Real Asset, Cantor/BSTR) and a new $200M IPO from FutureCorp, indicating a renewed appetite for space and tech-focused blank-check vehicles. Consumer-facing companies present a mixed picture: Nathan's Famous saw a 16.7% net income decline due to beef cost inflation, while Designer Brands beat EPS estimates on margin expansion. Period-over-period data highlights margin compression as a key risk, with Lands' End gross margins contracting 410 bps and UNFI's free cash flow halving, despite operational improvements. Insider activity is sparse, but high broker non-votes at several AGMs (CervoMed, Ooma) suggest passive investor disengagement or dissatisfaction.

27 high priority 23 medium 50 total filings
· daily

Global High-Priority Regulatory Events — June 09, 2026

The June 9, 2026 filing batch reveals a market sharply bifurcated between aggressive capital deployment (M&A, SPACs, IPOs) and deep distress (insolvencies, cash burn, regulatory penalties). The most critical development is GSK's $10.6B acquisition of Nuvalent at a 40% premium, signaling a major bet on precision oncology and validating the ROS1/ALK inhibitor space ahead of FDA decisions in September/November 2026. In parallel, the SPAC market is showing renewed vigor with three new business combination announcements (Inflection Point III, Inflection Point VI, IQM Finland), though the sector remains bifurcated between credible targets (Quantum Space, IQM) and cash-constrained entities like Ribbon Acquisition Corp. extending deadlines. On the distress side, Reliance Communications (72nd CoC meeting) and Vas Infrastructure (25th CoC meeting) underscore the prolonged nature of India's insolvency process, while Uranium Energy Corp's widening net loss (-$52.3M vs -$30.2M YoY) and zero sales in Q3 highlight the gap between balance sheet strength and operational performance. Period-over-period trends show a clear pattern: companies with recurring revenue models (Soluna Holdings +58% YoY, AITX +26% YoY) are outperforming those reliant on transactional sales (Nathans Famous -10.9% YoY, UEC -69.8% YoY sales decline). Insider activity is sparse but notable—Emkay Global's promoter warrant conversion signals confidence, while Cocrystal Pharma's CEO change introduces execution risk. Capital allocation is mixed: Sarla Performance's ₹44Cr buyback and Onward Technologies' tender offer signal shareholder returns, while Aspira Women's Health's dilutive $1.5M PIPE at $0.75/share highlights distress financing. The aggregate data suggests investors should favor companies with recurring revenue, strong balance sheets, and clear catalysts (FDA decisions, SPAC votes) while avoiding entities with negative operating cash flow, high leverage, or extended insolvency proceedings.

50 high priority 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — June 09, 2026

The 50 filings reveal a mixed landscape with notable M&A activity, SPAC developments, and mixed earnings results. Key themes include significant acquisitions in healthcare (GSK/Nuvalent $10.6B, Novanta/Riverpoint $1.45B), SPAC business combinations progressing (Inflection Point/Air Water, IQM/Real Asset), and mixed consumer results with Designer Brands and Lands' End showing revenue declines but margin improvements. Period-over-period trends highlight margin compression in food companies (Nathan's Famous beef costs up 19%) and technology (AITX revenue up 26% but still loss-making). Insider activity is limited, but capital allocation shows debt offerings (Cipher Mining $810M) and buybacks (News Corp $1B program). Forward-looking guidance is cautious (Smucker's FY27 sales decline 3-4%) but with some positive EPS growth expectations. The most critical development is

27 high priority 23 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — June 08, 2026

The June 8, 2026, filing batch reveals a market bifurcated between aggressive capital markets activity and significant corporate distress. A wave of debt and equity financing dominates, with $3.3 billion in new debt offerings from ATI, Hubbell, and FS KKR Capital Corp, alongside a $400 million convertible note from Celcuity, signaling robust credit appetite for investment-grade and BDC names. However, this is counterbalanced by three high-profile bankruptcies (GoHealth, Silver Star Properties, and a reverse merger from SUNation Energy), indicating severe stress in healthcare, real estate, and solar manufacturing. Governance upheaval is a key theme, with a CEO fired for misconduct at Perrigo, three directors removed at Pangaea Logistics, and a wave of director/officer resignations across multiple Invesco ETFs. The most transformative event is Nurix Therapeutics' $700 million upfront collaboration with Roche, a landmark biotech deal that dwarfs all other transactions in this batch. Insider activity is notably absent, but the lack of insider buying alongside the equity offerings suggests cautious management sentiment. The data points to a 'haves vs. have-nots' environment where well-capitalized firms are raising cheap debt for M&A, while over-levered entities are forced into restructuring.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — June 08, 2026

Today's filings reveal a market bifurcated between aggressive restructuring and strategic growth. The most critical developments are two high-profile bankruptcies (GoHealth and Silver Star Properties REIT) signaling distress in healthcare and real estate, contrasted with a landmark $700M upfront biotech collaboration (Nurix Therapeutics) and a transformative defense AI partnership (Palladyne AI). Period-over-period data shows a mixed earnings picture: Noble Romans swung to profitability (+$1.2M net income vs -$3K loss), while Duluth Holdings narrowed losses but saw sales decline 4% YoY. Capital allocation trends are divergent, with Ares Capital launching a $1B CP program for cheaper funding and Ciena announcing a $2B convertible note offering paired with a $140M buyback. Insider activity is limited, but the failed say-on-pay vote at nLIGHT (61% against) signals potential governance friction. The overarching theme is a 'survival of the fittest' environment where companies with strong balance sheets and strategic clarity (Nurix, Palladyne, Ciena) are positioning for growth, while overleveraged entities face existential restructuring.

25 high priority 25 medium 50 total filings
· daily

Global High-Priority Regulatory Events — June 08, 2026

The June 8, 2026, filing stream reveals a market bifurcated between aggressive capital restructuring and fundamental operational stress. The most critical event is the Chapter 11 filing by Silver Star Properties REIT (Materiality 10/10), signaling severe distress in commercial real estate, while GoHealth's prepackaged Chapter 11 (Materiality 9/10) highlights a strategic debt restructuring that will wipe out common equity. A wave of reverse mergers and SPAC deals is reshaping the small-cap landscape, with SUNation Energy's acquisition of Suniva (Materiality 9/10) creating a dominant U.S. solar cell manufacturer but diluting existing SUNE shareholders by 98.2%. On the positive side, Nurix Therapeutics' $700M upfront Roche collaboration (Materiality 9/10) and Bending Spoons' 237% revenue growth over two years (Materiality 9/10) represent standout opportunities in biotech and tech, respectively. Period-over-period trends show a mixed picture: Aeries Technology swung to profitability but on flat revenue, while FuelCell Energy's losses widened 103% YoY due to a $42.6M impairment. Portfolio-level patterns indicate a surge in debt financing (MSD Investment Corp tripling its unsecured debt limit to $600M, Ares Capital's $1B CP program) and a concerning number of insolvency/restructuring filings (Future Lifestyle, PS IT, Future Consumer, Silver Star, GoHealth). Insider activity is notably absent from most filings, but the board removals at Pangaea Logistics and the mass resignation of Jordan Krugman from five Invesco entities signal governance instability.

50 high priority 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — June 08, 2026

Overnight filings reveal a bifurcated market landscape: aggressive corporate restructurings and balance sheet maneuvers dominate, while select companies signal strong operational turnarounds and strategic pivots. Key themes include a wave of debt restructuring and bankruptcy filings (GoHealth, Silver Star Properties), significant M&A and partnership activity (Nurix/Roche $700M upfront, SUNation/Suniva reverse merger, Ciena $2B notes), and a notable number of shareholder compensation 'say-on-pay' failures (nLIGHT, Energy Recovery). Period-over-period data shows a sharp turnaround at Aeries Technology (swinging to $3.5M net income from -$21.6M loss) and Noble Romans (to $1.2M net income from -$3K loss), though revenue growth remains flat or negative for many. Insider activity is sparse, but capital allocation actions (Ciena buyback, Ares Capital CP program) provide positive signals. The most critical developments are the GoHealth and Silver Star bankruptcies, which signal distress in specific sectors, and the transformative Nurix-Roche deal, which validates the targeted protein degradation space.

25 high priority 25 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — June 05, 2026

The June 5, 2026 Material Events Monitor reveals a clear bifurcation between capital-intensive companies facing liquidity crises and tech/industrial firms executing strategic pivots. The most critical theme is **liquidity distress in capital-intensive sectors**: Americas Car-Mart (CRMT) secured only a 7-day lender forbearance while exploring strategic alternatives, and Phoenix Motor (PHOENIX) accepted a $5M term loan with onerous terms including a 49% equity option, signaling severe financing constraints. Conversely, the **AI and digital asset infrastructure sector** shows robust capital formation, with Bitmine Immersion Technologies (BMNR) upsizing a $273.8M preferred stock offering at 9.50% yield and Brand Engagement Network (BEN) completing a strategic AI-fleet investment. A notable **pattern of executive departures** spans 10+ companies, with several sudden resignations (Purple Innovation COO, Bionano Genomics CMO, Seadrill board dissent) weakening institutional knowledge. From period-over-period comparisons, **Gossamer Bio’s debt exchange** (90.5% tender, swapping 5% notes for 7.5% secured notes) reflects sector-wide refinancing stress. The most actionable insights cluster around **debt restructuring catalysts** (Seres Therapeutics, Gossamer Bio) and **mineral/energy asset digitization** (I-ON Digital, Northern Minerals), while the broad insider activity pattern of senior departures without named successors signals operational risk across multiple sectors.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — June 05, 2026

Today's filings reveal a stark divergence between transformative M&A and deteriorating consumer demand. The Berkshire Hathaway acquisition of Taylor Morrison Home Corp. is the clear highlight, signaling confidence in the US housing market by a premier value investor. This bullish signal is countered by significant headwinds in consumer discretionary, where Shoe Carnival and G-III Apparel reported sharp profit declines despite mixed revenue results, pointing to margin pressure from tariff costs and shifting demand. On the growth front, Planet Labs and Victoria's Secret posted exceptional revenue growth of 42.1% and 15.3% YoY, respectively, though Planet's net loss widened due to non-cash charges, and Victoria's Secret burned substantial cash on buybacks. The technology sector shows strength, with Guidewire Software’s subscription revenue surging 34.6% YoY, while energy services provider Ferrellgas reported an 11% decline in adjusted EBITDA due to warm weather and legacy costs. Capital markets remain active, with three new SPAC IPOs (Yorkville, RMG ML, JAB) filing or amending registrations, and several companies (iQSTEL, Gossamer Bio, Seres) executing strategic financial restructurings to improve balance sheets and liquidity.

21 high priority 29 medium 50 total filings
· daily

Global High-Priority Regulatory Events — June 05, 2026

The June 5, 2026, filing stream reveals a market bifurcated between aggressive capital deployment (buybacks, M&A, debt raises) and escalating financial distress, particularly in Indian small-caps and US cash-burning tech. A clear theme is the use of complex financial engineering to manage liabilities, with Gossamer Bio exchanging high-coupon debt for equity and Ferrellgas completing a major refinancing, while several companies like Shoe Carnival and Clean Energy Technologies show worsening cash positions. Insider activity is sparse but notable, with a significant pledge by a Paisalo Digital promoter and a complete change of control at P.H. Capital Ltd. via an open offer. Forward-looking statements are dominated by M&A catalysts, including a binding MOU from iQSTEL that could 4x net income and a non-binding LOI from FACT II Acquisition Corp. The most critical developments are the insolvency petition against TV Vision Ltd. and the continued delays in the Vikas WSP CIRP, signaling heightened credit risk in the Indian market. Overall, the data suggests investors should favor companies with strong organic growth and clean balance sheets (e.g., Victoria's Secret, Guidewire) while avoiding those with deteriorating liquidity and operational losses.

50 high priority 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — June 05, 2026

Overnight filings reveal a bifurcated market with aggressive capital deployment (M&A, buybacks, debt raises) contrasting with operational headwinds. The most critical development is Berkshire Hathaway's proposed acquisition of Taylor Morrison Home Corp (TMHC), a high-conviction bet on US housing. While several companies like Planet Labs (+42% YoY revenue) and Victoria's Secret (+15% YoY sales) show strong top-line growth, margin pressures and widening losses are common themes, with Shoe Carnival swinging to a net loss and G-III Apparel seeing an 8% sales decline. A significant capital allocation trend is visible: Guidewire repurchased $392M in stock, News Corp authorized a $1B buyback, and FTI Consulting added $370M to its repurchase program, signaling management confidence. However, this is offset by aggressive debt financing from Hut 8 ($4.25B notes), Northwest Natural ($195M total), and Gossamer Bio's debt exchange (90.5% participation), indicating a search for liquidity. A notable sector theme is the convergence of AI and physical infrastructure, seen in Brand Engagement Network's investment in fleet AI and Hut 8's massive data center debt raise.

22 high priority 28 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — June 04, 2026

The 50 filings reveal a mixed landscape with significant capital market activity, including large-scale refinancings (Marsh & McLennan's $4.25B credit facility, Cimpress's $1.35B refinancing), debt restructurings (Accuray's full repayment, CONMED's $645M note repurchase), and equity-linked financings (Syndax's $250M convertible notes). Several companies are pursuing strategic transformations: Resideo's ADI spin-off, Trulieve's deconsolidation, and Applied Aerospace's IPO preparations. Governance and compensation issues are prominent, with notable shareholder dissent at Sarepta (33% against say-on-pay), iHeartMedia (15.6% against), and BioMarin (13% against). Insider funding and liquidity concerns persist at NextTrip (related-party loans) and Avalon GloboCare (high-cost promissory note). Sector themes include increased leverage in insurance/brokerage, cannabis restructuring, and biotech equity plan expansions. No period-over-period revenue or margin trends are available from the filings, as most are event-driven 8-Ks without financial statements.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — June 04, 2026

Today's filings reveal a market bifurcated between strong operational momentum and significant financial engineering risks. A clear theme is the aggressive use of leverage and capital markets for transformative M&A, with QXO pricing $3.0B in notes for its TopBuild acquisition, Columbus McKinnon reporting a 24% revenue surge from the Kito Crosby deal but a $229.5M net loss due to a $200M goodwill impairment, and Gentherm announcing a Reverse Morris Trust acquisition to create a $2.6B revenue entity. Conversely, several companies show deteriorating fundamentals: X-Energy's net loss ballooned to $166.2M despite doubling revenue, CrowdStrike's cash position fell 12.9% due to acquisition spending, and PagSeguro's core transaction revenue declined 11.2% YoY. Insider financing and liquidity concerns are evident at NextTrip, which borrowed $200K from a director at 7.5% interest with a June 30 maturity, and America Great Health, which remains deeply insolvent with a $5.8M deficit. On the positive side, Ciena posted exceptional results with 39.5% revenue growth and raised guidance, Fractyl Health reported promising one-year data for its Revita procedure, and Genco Shipping is defending against an inadequate takeover bid while highlighting its strong dividend track record. The regulatory calendar is active with several key deadlines approaching, including the Leggett & Platt/Somnigroup merger clearing HSR review and the TruBridge acquisition vote scheduled for July 7.

20 high priority 30 medium 50 total filings
· daily

Global High-Priority Regulatory Events — June 04, 2026

The June 4, 2026 filing batch reveals a market bifurcated between robust operational strength in select industrials and deep distress in the travel/aviation and small-cap biotech sectors. The most critical development is IndiGo's massive reported net loss of ₹25,400 Cr in Q4 FY26, driven by an 11% rupee devaluation and geopolitical disruptions, though its underlying business remains profitable at ₹19,200 Cr. A wave of capital returns is evident, with Rolex Rings announcing a buyback at a 42% premium and Marsh & McLennan upsizing its credit facility by 21.4% to $4.25B, signaling strong balance sheet confidence. Conversely, liquidity crises are surfacing at NextTrip (insider loans at 7.5% maturing June 30) and America Great Health (cash down 36% to $28K). The SPAC market shows mixed activity, with Watu Metals launching a $100M IPO while Columbus Acquisition faces execution risk. A notable sector theme is the divergence in the cannabis space, where Trulieve's deconsolidation creates a cleaner medical cannabis entity but introduces a $688.7M one-time loss. Overall, the data points to a 'barbell' market: cash-rich companies are returning capital, while cash-poor entities face existential threats.

50 high priority 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — June 04, 2026

The overnight filing set (June 3-4, 2026) reveals a market dominated by transformative M&A and capital markets activity, with specific sector-level divergences. The energy and infrastructure sectors show mixed signals: **X-Energy** (X-energy) saw revenues surge 109% YoY to $43.4M but posted a steep $166.2M net loss driven by non-cash warrant charges, while **Columbus McKinnon** (CMCO) reported a 24% revenue jump to $1.19B but a $229.5M GAAP net loss including a $200M goodwill impairment. **Ciena** (CIEN) stands out as a top performer, with revenue up 39.5% YoY to $1.57B and adjusted EPS soaring 290%, while **Pyxus International** (PYX) showed Q4 revenue growth of 35.2% but guided FY2027 adjusted EBITDA below the record just achieved, signaling a peak. A wave of M&A activity is cresting: **Berkshire Hathaway** is acquiring **Taylor Morrison** (TMHC), **Gentherm** (THRM) is acquiring Modine's business (combined $2.6B revenue), **IKS** is acquiring **TruBridge** (TBRG) at an 87.5% premium, and **Somnigroup** (SNBR) and **Leggett & Platt** (LEG) cleared a key HSR hurdle. Insider and related-party financing at **NextTrip** (NTRP) and a Nasdaq non-compliance notice at **Smith-Midland** (SMID) highlight acute liquidity stresses. The SPAC market is active with filings from **Columbus Acquisition**, **Watu Metals**, and **Spring Valley** (General Fusion). Overall, the data suggests a bifurcated market where capital is flowing to high-growth tech and healthcare names, while legacy industrials and small-cap entities face margin pressure and leverage concerns.

20 high priority 30 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — June 03, 2026

The 50 filings from June 3, 2026, reveal a market bifurcated between aggressive growth plays and defensive refinancing. A clear theme is the acceleration of AI and data infrastructure, with Netskope (ARR +29% YoY) and CXApp (revenue to triple via acquisition) leading, while SPACs like Hall Chadwick ($400M REEcycle deal) and Tribeca ($140M IPO) signal continued appetite for high-growth narratives. However, this is contrasted by significant financial distress signals: Katapult has amended its credit facility eleven times, DevvStream faces a default notice, and Lottery.com issued a high-cost 12% note. Capital allocation is mixed, with TTM Technologies upsizing and repricing debt (saving 50 bps), while others like LightPath and Amtech are tapping equity markets. Insider activity is sparse but notable, with CEO departures at Energy Transfer, MillerKnoll, and SpringBig, and a highly contested say-on-pay at Douglas Emmett (50/50 split). The overarching trend is a 'haves vs. have-nots' market where strong operators are investing for growth, while weaker balance sheets are forced into dilutive or high-cost financing.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — June 03, 2026

Today's filings reveal a mixed landscape with notable capital market activity: several companies announced debt offerings (Arch Capital $2B, Dorman Products $450M) and at-the-market equity programs (Intuitive Machines $500M, Astrotech $24.5M), signaling a focus on balance sheet management. Earnings reports show divergence: Palo Alto Networks revenue surged 31% YoY but swung to a net loss due to acquisition costs, while THOR Industries saw a 28% profit decline amid RV market headwinds. Medtronic posted its highest annual revenue growth in a decade but margins contracted. Insider activity was limited, but notable capital allocation shifts include Vertiv's first dividend and News Corp's ongoing $1B buyback. Several biotech firms (Mineralys, Cabaletta, Avalyn) reported mixed clinical data or financing events, creating both opportunities and risks. Overall, themes of debt refinancing, margin pressure, and selective growth emerge.

22 high priority 28 medium 50 total filings